Profibrinolytic properties characterize a stably transformed human endothelial cell line

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 2, 1998, Pages 153-165

  Camera, M ^a   Hajjar, K A ^a   Pan, S ^a   Szabo, P ^a   Vicart, P ^a   Paulin, D ^a   Weksler, B B ^a  

^a NY USA   (United States)

Author keywords

Fibrinolysis; Human endothelial cell line; Plasminogen activator inhibitors; Plasminogen activators; Regulation

Indexed keywords

ARTICLE; CELL IMMORTALIZATION; CELL TRANSFORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBRINOLYSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 0031979140     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199803000-00006     Document Type: Article

References (41)

1. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. / Cardiovasc Pharwwco/1993;22:Sl-S14.
2. Goldsmith JC, McCormick JJ, Yen A. Endothelial cell cycle kinetics. Changes in culture and correlation with endothelial properties. Lab Invest 1984; 51: 643-647.
3. Dichek D, Quertermous T. Thrombin regulation of mRNA levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells. Blood 1989; 74: 222228.
4. Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VHI-related antigen established by hybridization. Proc Natl Acad Sei USA 1983; 80: 3734-3737.
5. Faller DV, Kourembanas S, Ginsberg D, Hannan R, Collins T, Ewenstein BM, et al. Immortalization of human endothelial cells by murine sarcoma viruses without morphologic transformation. / Cell Physiol 1988; 134: 47-56.
6. Pickling SA, Tooze JA, Whitley GSJ. Characterization of human umbilical vein endothelial cell lines produced by transfection with the early region of SV40. Exp Cell Res 1992; 201: 517-521.
7. Durieu-Trautman O, Foignant-Chaverot N, Perdomo J, Gounon P, Strosberg AD, Couraud PO. Immortalization of brain capillary endothelial cells with maintenance of structural characteristics of the blood-brain barrier endothelium. In Vitro Cell Dev Biol 1991; 27A: 771-778.
8. Takahashi K, Sawasaki Y, Hata JI, Mukai K, Goto T. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol 1990; 25: 265-274.
9. Gimbrone MA Jr, Freed GC. Transformation of cultured human vascular endothelium by SV40 DNA. Cell 1976; 9: 685-693.
10. Schwanz B, Vicart P, Delouis C, Paulin D. Mammalian cell lines can be efficiently established in vitro upon expression of the SV40 large T antigen driven by a promoter sequence derived from the human vimemin gene. Biol Cell 1991; 73: 7-14.
11. Vicart P, Testut P, Schwanz B, Llorens-Cortes C, Perdomo JJ, Paulin D. Cell adhesion markers are expressed by a stable human endothelial cell line transformed by the SV40 large T antigen under vimentin promoter control. / Cell Pbysiol 1993; 157: 41-51.
12. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. / Clin Invest 1973; 52: 2745-2756.
13. Maciag T, Cerundolo J, Ilsley S, Kelley PR, Forand R. An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sd USA 1979; 76: 5674-5678.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
15. Andreasen PA, Riccio A, Welinder KG, Douglas R, Sartorio R, Nielsen LS, et al. Plasminogen activator inhibitor type-1. Reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing. FEES Lett 1986; 209: 213-218.
16. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. JBiol Chem 1994; 269: 21191-21197.
17. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory; 1989.
18. Hajjar KA, Guevara CA, Lev E, Dowling K, Chacko J. Interaction of the fibrinolytic receptor, Annexin II, with the endothelial cell surface: essential role of endonexin repeat II. / Biol Cbem 1996; 271: 2165221659.
19. van Hinsbergh VW, Binnema D, Scheffer MA, Sprengers ED, Kooistra T, Rijken DC. Production of plasminogen activators and inhibitor by serially propagated endothelial cells from adult human blood vessel. Arteriosclerosis 1987; 7: 389-400.
20. van Hinsbergh VW, van den Berg EA, Fiers \V, Dooijewaard G. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. Blood 1990; 75: 1991-1998.
21. Sato Y, Rifkin DB. Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol 1988; 107: 1199-1206.
22. Saksela O, Rifkin DB. Cell-associated plasminogen activation: regulation and physiological functions. Anna Rev Cell Biol 1988; 4: 93-126.
23. van den Berg EA, Sprengers ED, Jaye M, Burgess W, Maciag T, van Hinsbergh VWM. Regulation of plasminogen activator inhibitor-1 mRNA in human endothelial cells. Thromb Haemost 1988; 60: 63-67.
24. Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone M Jr, Loskutoff DJ. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. / Biol Chem 1988; 263: 5797-5803.
25. Gelehrter TD, Sznycer-Laszuk R. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells./ Clin Invest 1986; 77: 165-169.
26. Colucci M, Paramo JA, Collen D. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. ] Clin Invest 1985; 75: 818-824.
27. Emeis JJ, Kooistra T. Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. / Exp Med 1986; 163: 1260-1266.
28. Santell L, Levin EG. Cyclic AMP potentiates phorbol ester stimulation of tissue plasminogen activator release and inhibits secretion of plasminogen activator inhibitor-1 from human endothelial cells. / Biol Chem 1988; 263: 16802-16808.
29. Webb AC, Collins KL, Snyder SE, Alexander SJ, Rosenwasser LJ, Eddy RL, et al. Human monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitor. J Exp Med 1987; 166: 77-94.
30. Levin EG, Loskutoff DJ. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. / Cell Biol 1983; 94: 631-636.
31. Levin EG. Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex. Proc Natl Acad Sei USA 1983; 80: 6804-6808.
32. Rijken DC, Van Hinsberg VWM. Quantitäten of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay. Thromb Res 1984; 33: 145-153.
33. Martin NB, Jamieson A, Rutter H, Tuffin DP. A comparison of fibrinolytic capacity and response to TNF-a stimulation in the cultured endothelial cell lines ECV304 and EA.hy.926. Fibrinolysis 1994; 8: 147-155.
34. Saksela O, Moscatelli D, Rifkin DB. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. / Cell Biol 1987; 105: 957-963.
35. Dana K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985; 44: 139-266.
36. Booyse FM, Osikowicz G, Feder S, Scheinbuks J. Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54, 000) from cultured human endothelial cells indistinguishable from urinary urokinase. / Biol Chem 1984; 259: 7198-7205. '
37. Booyse FM, Scheinbuks J, Radek J, Osikowicz G, Feder S, Quarfoot AJ. Immunological identification and comparison of plasminogen activator forms in cultured normal human endothelial cells and smooth muscle cells. Tbromb Res 1981; 24: 495-504.
38. van Hinsbergh VWM, Sprengers ED, Kooistra T. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb Haemost 1987; 57: 148-153.
39. Cohen RL, Niclas J, Lee WM, Wun TC, Crowley CW, Levinson AD, et al. Effects of cellular transformation on expression of plasminogen activator inhibitors 1 and 2. Evidence for independent regulation. / Biol Chem 1989; 264: 8375-8383.
40. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368: 419-424.
41. Munson PJ, Rodbard D. Ligand: a versatile computerized approach for characterization of ligand binding sites. AnalBiochem 1980; 7: 220-239.